KYMR

Kymera Therapeutics, Inc. Common Stock

74.71

USD

KYMR Earnings Reports

Positive Surprise Ratio

KYMR beat 6 of 21 last estimates.

29%

Next Report

Date of Next Report

Feb 25, 2026

Estimate for Q4 25 (Revenue/ EPS)

$15.47M

-$0.81

Implied change from Q3 25 (Revenue/ EPS)

+459.71%

-13.83%

Implied change from Q4 24 (Revenue/ EPS)

+109.23%

-7.95%

Kymera Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 04, 2025, KYMR reported earnings of -0.94 USD per share (EPS) for Q3 25, missing the estimate of -0.82 USD, resulting in a -14.63% surprise. Revenue reached 2.76 million, compared to an expected 19.33 million, with a -85.70% difference. The market reacted with a +0.32% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 25 analysts forecast an EPS of -0.81 USD, with revenue projected to reach 15.47 million USD, implying an decrease of -13.83% EPS, and increase of 459.71% in Revenue from the last quarter.

FAQ

What were Kymera Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Kymera Therapeutics, Inc. Common Stock reported EPS of -$0.94, missing estimates by -14.63%, and revenue of $2.76M, -85.7% below expectations.

How did the market react to Kymera Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 0.32%, changed from $59.72 before the earnings release to $59.91 the day after.

When is Kymera Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Feb 25, 2026.

What are the forecasts for Kymera Therapeutics, Inc. Common Stock's next earnings report?

Based on 25 analysts, Kymera Therapeutics, Inc. Common Stock is expected to report EPS of -$0.81 and revenue of $15.47M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.